home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

Industry Advisers

Set up in December 2009, EPC’s board of Industry Advisers help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.

Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development

Beatrijs Van Liedekerke
Director, Advisory Services

Henrietta Ukwu
Senior Vice President, Global Regulatory Affairs
PPD, Inc

Jane Clarke
Director, eTMF Document Solutions and System Development

For further information please contact:

Jonathan Smith

Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

View the digital version of EPC

Featured in this issue
Clinical Trials: Patient Recruitment & Retention
Trial Recruitment

A Rare Find

Recruitment and retention can be a hard task for most clinical trials, but when the study area is an ultra-rare disease like alkaptonuria, every patient really does count, says Hana Ayoob at the AKU Society.
Therapeutic Innovation: Cancer Focus
Automated Colony Analysis

Counting Costs

Michael Rau
from Oxford Optronix describes how CROs can use automated colony counting systems to resolve the capacity and scalability conundrum – ensuring they remain fl exible and costeffective in areas such as colony forming cell assays.
  Electronic Solutions
Compliance Programmes

Do the Right Thing

Pharma invests heavily in compliance, and yet it is still no stranger to scandals and government investigations. Seth Berman at Stroz Friedberg discusses how tailored training, policies and software can help reinforce a culture of compliance from the top down.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December

Banner of Hermes.EPC.PMPS on Samedan
Banner of Trilogy.EPC on Samedan
Industry Events

European Lab Automation 2014

13-15 May 2014, Barcelona, Spain

SELECTBIO is pleased to announce the 4th annual European Lab Automation, Europe’s premier event dedicated to automation within the life sciences.
More info >>

News and Press Releases

Webinar Polls Shows Packaging Solutions Offer Ideal Way To Meet Falsified Medicines Directive Challenges

The results from polls taken at a recent webinar attended by representatives from the pharma sector highlight the industry’s progress in meeting the requirements of the Falsified Medicines Directive (FMD).
More info >>

air transport logo


White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement